YB-1 Oncoprotein Controls PI3K/Akt Pathway by Reducing Pten Protein Level

Area of Science:

• Oncology
• Molecular Biology
• Cellular Signaling

Background:

• Y-box binding protein 1 (YB-1) is an oncoprotein overexpressed in various cancers, regulating cell progression and proliferation.
• YB-1's function is dependent on subcellular localization, primarily in the cytoplasm regulating mRNA translation and stability, but translocating to the nucleus as a prosurvival factor under stress.
• YB-1 is implicated in regulating diverse signaling pathways and acts as a sensor for oxidative stress and DNA damage.

Purpose of the Study:

• To investigate the role of YB-1 in regulating the PTEN/PI3K/Akt signaling pathway.
• To determine the mechanism by which YB-1 influences PTEN levels.
• To elucidate how YB-1 overexpression contributes to cancer cell survival and proliferation.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess PTEN mRNA levels.
• Cellular assays in human immortalized keratinocytes and HEK293T cells to evaluate YB-1 effects on PTEN.
• Proteasome inhibition assays to investigate PTEN degradation.

Main Results:

• YB-1 overexpression leads to reduced intracellular PTEN levels, consequently activating the PI3K/Akt pathway.
• The reduction in PTEN levels mediated by YB-1 is observed in multiple cell types and is not reversed by proteasome inhibition.
• YB-1 silencing results in increased PTEN mRNA levels, indicating negative transcriptional control.

Conclusions:

• YB-1 negatively regulates PTEN at the transcript level.
• YB-1 overexpression confers a survival and proliferative advantage to cancer cells, even those proficient in PTEN.
• Targeting YB-1 may offer a therapeutic strategy for cancers driven by the PTEN/PI3K/Akt pathway.